BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11749869)

  • 1. Inhibition of regrowth of prostatic glandular cells by epristeride.
    Qian LH; Wang XL; Tu ZH
    Acta Pharmacol Sin; 2001 Sep; 22(9):847-50. PubMed ID: 11749869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible long-term toxicity of epristeride in beagle dogs.
    Sun ZY; Feng J; Qi XD; Wu HY; Zheng WJ; Tu ZH
    Toxicol Appl Pharmacol; 1999 Jan; 154(2):145-52. PubMed ID: 9925798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cultured rat prostatic epithelial cell growth by epristeride in vitro.
    Wu SF; Sun HZ; Tu ZH; Wu HY
    Acta Pharmacol Sin; 2001 Mar; 22(3):257-63. PubMed ID: 11742574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of epristeride on expression of TGF-beta receptor in rat prostatic epithelial cells in vitro.
    Wu SF; Sun HZ; Tu ZH; Wu HY
    Acta Pharmacol Sin; 2001 Jun; 22(6):516-20. PubMed ID: 11747757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophy and apoptosis in ventral prostate of rats induced by 5alpha-reductase inhibitor, epristeride.
    Qian LH; Wang XL; Tu ZH
    Acta Pharmacol Sin; 2001 May; 22(5):399-404. PubMed ID: 11743885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
    Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
    Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of large-dosage of 5alpha-reductase inhibitors on the spermatogenesis of male rats].
    Wang XD; Jia Y; Cui YG; Wang XH; Tong JS; Ma DZ; Cai RF; Di FS
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):652-4. PubMed ID: 16209201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of glutathione-peroxidase (GSH-PO) in the rat ventral prostate--effect of castration and administration of testosterone.
    Murakoshi M; Ikeda R; Tagawa M; Suzuki M; Takekoshi S; Watanabe K
    Tokai J Exp Clin Med; 1997 Sep; 22(3):111-8. PubMed ID: 9618832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5alpha-reductase inhibitor.
    Lu YL; Kuang L; Zhu H; Wu H; Wang XF; Pang YP; Wang NJ; Yu DL
    Asian J Androl; 2007 Nov; 9(6):843-7. PubMed ID: 17968472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new 5 alpha reductase inhibitor (epristeride) on human prostate cell cultures.
    Robinson EJ; Collins AT; Robson CN; Neal DE
    Prostate; 1997 Sep; 32(4):259-65. PubMed ID: 9288184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of vitamin D in normal prostate growth and differentiation.
    Konety BR; Schwartz GG; Acierno JS; Becich MJ; Getzenberg RH
    Cell Growth Differ; 1996 Nov; 7(11):1563-70. PubMed ID: 8930406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
    Wu SF; Sun HZ; Qi XD; Tu ZH
    Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats.
    Yasuda N; Fujino K; Shiraji T; Nambu F; Kondo K
    Jpn J Pharmacol; 1997 Jul; 74(3):243-52. PubMed ID: 9268084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of testosterone 5 alpha-reductase: evidence for tissue-specific regulation of thromboxane A2 receptors.
    Higashiura K; Blaney B; Morgan E; Mathur RS; Halushka PV
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1386-91. PubMed ID: 8968363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U; McNamara K; Gao YR; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epididymis in an experimental model of DHT deficiency: immunolocalization of ERalpha and ERbeta in rat epididymal epithelial cells. In vivo and in vitro studies].
    Kolasa A
    Ann Acad Med Stetin; 2006; 52(2):13-21; discussion 21. PubMed ID: 17633123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E; Bernoulli J; Talvitie EM; Santti R
    Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of prostatic hyperplasia model with castration beagle canines].
    Wu JH; Sun ZY; Zhu Y; Zhong EH; He GL; Liu GM
    Zhonghua Nan Ke Xue; 2003 Sep; 9(6):425-8. PubMed ID: 14574805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.